Precision BioSciences to Participate in Upcoming Guggenheim Healthcare Talks Conference

Precision BioSciences, Inc. a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that the Company will... | March 27, 2023

Related Keywords

,Precision Biosciences Inc ,Lotte New York Palace Hotel ,Nasdaq ,Precision Biosciences ,Guggenheim Healthcare Talks ,Genomic Medicines ,Rare Disease Days ,Nc Stock Exchange ,News ,Information ,Press Release ,Precision ,Linical ,Stage ,Gene ,Editing ,Company ,Developing ,Sex ,Ivo ,Allogeneic ,Ear ,End ,N ,Oday ,Nnounced ,Hat ,The ,Ompany Dtil Us74019p1084 ,